Characterization of prostaglandin endoperoxide H synthase-1 enzyme expression during differentiation of the megakaryocytic cell line MEG-01

Experimental Hematology

Volumn 28, Issue 4, 2000, Pages 411-421

  Mroske, Cameron ^a   Plant, Matthew H ^a   Franks, Douglas J ^a,b   Laneuville, Odette ^a  

^a Departments of Biochemistry   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cyclooxygenase; Differentiation; Megakaryocyte; Platelet

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; ISOENZYME; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MEGAKARYOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 1; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEGAKARYOCYTES; MEMBRANE PROTEINS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 0034011643     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00125-9     Document Type: Article

References (56)

1. Smith W.L., Marnett L.J. Prostagladin endoperoxide synthase. structure and catalysis Biochim Biophys Acta. 1083:1991;1.
2. Hamberg M., Svenson J., Samuelsson B. Thromboxanes. a new group of biologically active compounds derived from prostaglandin endoperoxides Proc Natl Acad Sci U S A. 72:1975;2994.
3. Goldhaber S.Z., Manson J.E., Stampfer M.J.et al. Low-dose aspirin and subsequent peripheral arterial surgery in the physicians' health study. Lancet. 340:1992;143.
4. Boger R.H., Bode-Boger S.M., Gutszki F.M., Tsikas D., Weskott H.P., Frolich J.C. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin. Clin Sci. 84:1993;517.
5. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 330:1994;1287.
6. Schadlich P.K., Brecht J.G. Cost-effectiveness of prevention of reinfarction using low-dose acetylsalicylic acid. model calculation Sozial Praventivemedizin. 42(s):1997;114.
7. Funk C.D., Funk L.B., Kennedy M.E., Pong A.S., Fitzgerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase. cDNA cloning, expression, and gene chromosomal assignment FASEB J. 5:1991;2304.
8. Willard J., Lange R.A., Hillis L.D. The use of aspirin in ischemic heart disease. N Engl J Med. 327:1992;175.
9. DeWitt D.L., Smith W.L. Primary structure of sheep prostaglandin endoperoxide synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci U S A. 85:1988;1412.
10. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbyl ester tumor promotor-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygen ase homologue. J Biol Chem. 266:1991;12866.
11. Kujubu D.A., Reddy S.T., Fletcher B.S., Herschmann H.R. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem. 268:1993;5425.
12. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase-2. Eur J Biochem. 221:1994;889.
13. Smith W.L., Laneuville O. Cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism. Harris J.E., Braun D.P., Anderson K.M. Prostaglandin inhibitors in tumor immunology and immunotherapy. 1994;CRC Press, London. 1p.
14. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 271:1996;33157.
15. DeWitt D.L., El-Harith E.A., Kraemer S.A., Andrews M.J., Yao E.F., Armstrong R.L., Smith W.L. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem. 265:1990;5192.
16. Lecomte M., Laneuville O., Ji C., DeWitt D.L., Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 269:1994;13207.
17. Herchman H.R. Prostaglandin synthase 2. Biochim Biophys Acta. 1295:1996;125.
18. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 91:1994;12013.
19. Hedin L., Gaddy-Kurten D., Kurten R., DeWitt D.L., Smith W.L., Richards J.S. Prostaglandin endoperoxide synthase in rat ovarian follicles. content, cellular distribution and evidence for hormonal induction preceding ovulation Endocrinology. 121:1987;722.
20. Wong W.Y.L., DeWitt D.L., Smith W.L., Richards J.S. Rapid induction of prostaglandin endoperoxide synthase in rat preovulatory follicles by luteinizing hormone and cAMP is blocked by inhibitors of transcription and translation. Mol Endocrinol. 3:1989;1714.
21. Sirois J., Simmons D.L., Richards J. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. J Biol Chem. 267:1992;11586.
22. Mazur E.M. Megakaryocytopoiesis and platelet production. a review Exp Hematol. 15:1987;340.
23. Breton-Gorius J., Vainchenker W. Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Semin Hematol. 23:1986;43.
24. Ogura M., Morishima Y., Okumura M., Hotta T., Takamoto S., Ohno R., Hirabayashi N., Nagura H., Saito H. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbyl diesters. Blood. 72:1988;49.
25. Isenberg W.M., Baiton D.F. Megakaryocyte and platelet structure. Hoffman R., Benz E.J. Jr., Shattish S.J., Furie B., Cohen H.J., Silberstein L.E. Hematology basic principles and practice. 1995;Churchill Livingstone, New York. 1516p.
26. Hayhoe F.G.J., Quaglino D. Phosphatases, esterases. Hayhoe F.G.J., Quaglino D. Haematological cytochemistry. 1981;Churchill Livingston, New York. 105p.
27. Ogura M., Yasuo M., Ohno R.et al. Establishment of a novel leukemia cell line MEG-01, with positive Philadelphia chromosome. Blood. 66:1985;1384.
28. Takeuchi K., Ogura M., Saito H., Satoh M., Takeuchi M. Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01). Exp Cell Res. 193:1991;223.
29. Takeuchi M., Kuno H., Saito M., Yoshida T., Ogura M., Takeuchi K. Platelet-like particles released by inhibition of DNA synthesis in the human megakaryoblastic cell line, MEG-01s. Tissue Culture Res Commun. 14:1995;165.
30. Takeuchi K., Satoh M., Kuno H., Yoshida T., Kondo H., Takeuchi M. Platelet-like particle formation in the human megakaryoblastic leukemia cell lines MEG-01 and MEG-01s. Br J Haematol. 100:1998;436.
31. Tabilio A., Vainchenker W., Van Haecke D.et al. Immunological characterization of the leukemic megakaryocytic cell line at light and electron microscopic levels. Leukemia Res. 8:1984;769.
32. Baatout S. Phorbyl esters. useful tools to study megakaryocyte differentiation Hematol Cell Ther. 40:1998;33.
33. Vainchenker W., Keiffer N. Human megakaryopoiesis. in vitro regulation and characterization of megakaryocyte precursor cells by differentiation markers Blood Rev. 2:1988;102.
34. Debili N., Issaad C., Masse J.M.et al. Expression of CD34 and platelet glycoproteins during megakaryocytic maturation. Blood. 80:1992;3022.
35. Debili N., Kieffer N., Nakazawa M.et al. Expression of platelet glycoprotein Ib by cultured human megakaryocytes. ultrastructural localization and biosynthesis Blood. 76:1990;368.
36. Vainchenker W., Deschamps J.F., Bastin J.M.et al. Two monoclonal antibodies as markers of human megakaryocyte maturation. immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients Blood. 59:1982;514.
37. Breton-Gorius J., Vanhaeke D., Tabilio A., Vainchenker W., Deschamps J.F., Xu F.S. Glycoprotein I identification during normal and pathological megakaryocytic maturation. Blood Cells. 9:1983;275.
38. Vinci G., Tabilio A., Deschamps J.F.et al. Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol. 56:1984;589.
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:1976;248.
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680.
41. Stefanini M., De Martino C., Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature. 216:1967;173.
42. Plant M.H., Laneuville O. Characterization of a novel transcript of prostaglandin endoperoxide H synthase-1 with a tissue-specific profile of expression. Biochem J. 344:1999;677.
43. Cedergren B. Separation and blood component therapy. Larkartidningen. 69(suppl. 4):1972;59.
44. Bhagwat S.S., Hamann P.R., Still W.C., Bunting S., Fitzpatrick F.A. Synthesis and structure of the platelet aggregating factor thrombxane A2. Nature. 315:1985;511.
45. Ueda N., Yamashita R., Yamamoto S., Ishimura K. Induction of cycloocygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbyl ester. Biochem Biophys Acta. 1344:1997;103.
46. Morita I., Schindler M., Regier M.K.et al. Different intracellular location for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem. 270:1995;10902.
47. Spencer A.G., Woods J.W., Arakawa T., Singer I.I., Smith W.L. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem. 273:1998;9886.
48. Picot D., Loll P.J., Garavito R.M. The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367:1994;243.
49. Levine R.F., Eldor A., Shoff P.K., Kirwin S., Tenza D., Cramer E.M. Circulating megakaryocytes. delivery of large numbers of intact, mature megakaryocytes to the lungs Eur J Haematol. 51:1993;233.
50. Vuillet-Gaugler M.H., Breton-Gorius J., Vainchenker W.et al. Loss of attachment with terminal human erythroid differentiation. Blood. 75:1990;865.
51. Zauli G., Vitale M., Falcieri E.et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood. 90:1997;2234.
52. Berthier R., Jacquier-Sarlin M., Schweitzer A., Block M.R., Molla A. Adhesion of mature polyploid megakaryocytes to fibronectin is mediated by β integrins and leads to cell damage. Exp Cell Res. 242:1998;315.
53. Rabellino E.M., Levene R.B., Leung L.L.K., Nachman R.L. Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med. 154:1981;88.
54. Levene R.B., Lamaziere J.M.D., Broxmeyer H.E., Lu L., Rabellino E.M. Human megakaryocytes V. Changes in the phenotypic profile of differentiating megakaryocytes. J Exp Med. 161:1985;457.
55. Damiani G., Zocchi E., Fabbi M., Bargellesi A., Patrone F. A monoclonal antibody to platelet glycoproteins IIb and IIa complex. its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorecence studies of Ia-like antigens Exp Hematol. 11:1983;169.
56. Zauli G., Cantini L., Gibellini D.et al. Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1 related thrombocytopenia. Br J Haematol. 92:1996;711.